Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer
Zi Liu(University of Chinese Academy of Sciences), Guang‐Biao Zhou(Institute of Zoology)
Cited by 105
Related Papers
Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors
|Oncotarget|2015|65
Small Compound 6-O-Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potentials in Multiple Myeloma
|PLoS ONE|2011|49